News

The United States diabetes drugs market size is projected to exhibit a growth rate (CAGR) of 3.55% during 2025-2033. The ...
Thanks to his trusty Dexcom continuous glucose monitor (CGM), former boy band star Lance Bass is saying “bye bye bye” to ...
Managing type 1 diabetes isn’t just about insulin. Find out how men can overcome the mental hurdles and build a healthier, more resilient life.
Discover expert tips from an obesity medicine doctor on effective and sustainable ways to approach weight loss for type 2 diabetes.
Originally developed for patients with diabetes, continuous glucose monitors have the potential to improve earlier stages of blood glucose dysfunction, too.
The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a ...
TORONTO, May 28, 2025 /CNW/ - Diabetes Express, a division of Bayshore HealthCare, is proud to sponsor "Cycle for Type 1" a coast-to-coast cycling journey undertaken by an individual with type 1 ...
PurpleLab and Genentech executives will explore how to leverage real world data to eliminate blind spots in the patient journey — informing every phase of a drug’s lifecycle, from clinical ...
Josh Marsh, Vice President and General Manager of Cardinal Health Sonexus™ Access and Patient Support, outlines the recent shift in the patient services industry towards a hybrid hub model for ...
To register for the webinar Eliminating Blind Spots in the Patient Journey, scheduled for 1-2 pm ET on May 22, please fill out the form below: Photo:Eugene Mymrin, Getty Images ...